Magellan Health (MGLN) Tops Q4 EPS Views; Guides FY15 EPS
Get Alerts MGLN Hot Sheet
Join SI Premium – FREE
Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.32, $0.81 better than the analyst estimate of $0.51. Revenue for the quarter came in at $982.5 million versus the consensus estimate of $980.37 million.
Magellan Health sees FY2015 EPS of $3.33-$3.79, versus the consensus of $2.36.
For earnings history and earnings-related data on Magellan Health (MGLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walgreens Boots Alliance (WBA) tops Q2 expectations, narrows full-year profit forecast
- Sprinklr (CXM) Tops Q4 EPS by 4c; offers guidance
- Franklin Covey (FC) Tops Q2 EPS by 1c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!